Project delivery performance: Insights from English roads major schemes von Chapman, Paul

Volltext

Targeting Tumor-Rejection Antigens in Melanoma With Tumor-Infiltrating Lymphocytes von Chapman, Paul B.

Volltext

Experimental human hookworm infection: a narrative historical review von Chapman, Paul R, Giacomin, Paul, Loukas, Alex, McCarthy, James S

Volltext

Treatment Outcomes of Immune-Related Cutaneous Adverse Events von Phillips, Gregory S, Wu, Jennifer, Hellmann, Matthew D, Postow, Michael A, Rizvi, Naiyer A, Freites-Martinez, Azael, Chan, Donald, Dusza, Stephen, Motzer, Robert J, Rosenberg, Jonathan E, Callahan, Margaret K, Chapman, Paul B, Geskin, Larisa, Lopez, Adriana T, Reed, Vanessa A, Fabbrocini, Gabriella, Annunziata, Maria Carmela, Kukoyi, Oluwaseun, Pabani, Aliyah, Yang, Chih-Hsun, Chung, Wen-Hung, Markova, Alina, Lacouture, Mario E

Volltext

Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET von Peinado, Héctor, Alečković, Maša, Lavotshkin, Simon, Matei, Irina, Costa-Silva, Bruno, Moreno-Bueno, Gema, Hergueta-Redondo, Marta, Williams, Caitlin, García-Santos, Guillermo, Ghajar, Cyrus M, Nitadori-Hoshino, Ayuko, Hoffman, Caitlin, Badal, Karen, Garcia, Benjamin A, Callahan, Margaret K, Yuan, Jianda, Martins, Vilma R, Skog, Johan, Kaplan, Rosandra N, Brady, Mary S, Wolchok, Jedd D, Chapman, Paul B, Kang, Yibin, Bromberg, Jacqueline, Lyden, David

Volltext

Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial von Long, Georgina V, Dr, Trefzer, Uwe, MD, Davies, Michael A, MD, Kefford, Richard F, Prof, Ascierto, Paolo A, MD, Chapman, Paul B, MD, Puzanov, Igor, MD, Hauschild, Axel, MD, Robert, Caroline, PhD, Algazi, Alain, MD, Mortier, Laurent, Prof, Tawbi, Hussein, PhD, Wilhelm, Tabea, MD, Zimmer, Lisa, MD, Switzky, Julie, MSN, Swann, Suzanne, PhD, Martin, Anne-Marie, PhD, Guckert, Mary, MSN, Goodman, Vicki, MD, Streit, Michael, MD, Kirkwood, John M, Prof, Schadendorf, Dirk, Prof

Volltext

Dabrafenib in BRAF -mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial von Hauschild, Axel, Prof, Grob, Jean-Jacques, Prof, Demidov, Lev V, Prof, Jouary, Thomas, MD, Gutzmer, Ralf, MD, Millward, Michael, MD, Rutkowski, Piotr, PhD, Blank, Christian U, PhD, Miller, Wilson H, PhD, Kaempgen, Eckhart, PhD, Martín-Algarra, Salvador, PhD, Karaszewska, Boguslawa, MD, Mauch, Cornelia, Prof, Chiarion-Sileni, Vanna, MD, Martin, Anne-Marie, PhD, Swann, Suzanne, PhD, Haney, Patricia, BSN, Mirakhur, Beloo, PhD, Guckert, Mary E, MSN, Goodman, Vicki, MD, Chapman, Paul B, MD

Volltext

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma von Flaherty, Keith T, Puzanov, Igor, Kim, Kevin B, Ribas, Antoni, McArthur, Grant A, Sosman, Jeffrey A, O'Dwyer, Peter J, Lee, Richard J, Grippo, Joseph F, Nolop, Keith, Chapman, Paul B

Volltext

PD-1 or PD-L1 Blockade Adds Little to Combination of BRAF and MEK Inhibition in the Treatment of BRAF V600-Mutated Melanoma von Callahan, Margaret K, Chapman, Paul B

Volltext

Long-Term Outcomes and Responses to Retreatment in Patients With Melanoma Treated With PD-1 Blockade von Betof Warner, Allison, Palmer, Jessica S, Shoushtari, Alexander N, Goldman, Debra A, Panageas, Katherine S, Hayes, Sara A, Bajwa, Raazi, Momtaz, Parisa, Callahan, Margaret K, Wolchok, Jedd D, Postow, Michael A, Chapman, Paul B

Volltext

RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E) von Poulikakos, Poulikos I., Persaud, Yogindra, Janakiraman, Manickam, Kong, Xiangju, Ng, Charles, Moriceau, Gatien, Shi, Hubing, Atefi, Mohammad, Titz, Bjoern, Gabay, May Tal, Salton, Maayan, Dahlman, Kimberly B., Tadi, Madhavi, Wargo, Jennifer A., Flaherty, Keith T., Kelley, Mark C., Misteli, Tom, Chapman, Paul B., Sosman, Jeffrey A., Graeber, Thomas G., Ribas, Antoni, Lo, Roger S., Rosen, Neal, Solit, David B.

Volltext

Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memor... von Horvat, Troy Z, Adel, Nelly G, Dang, Thu-Oanh, Momtaz, Parisa, Postow, Michael A, Callahan, Margaret K, Carvajal, Richard D, Dickson, Mark A, D'Angelo, Sandra P, Woo, Kaitlin M, Panageas, Katherine S, Wolchok, Jedd D, Chapman, Paul B

Volltext

Changing the standard of care for treating melanoma brain metastases von Chapman, Paul B

Volltext

Combination of RAF and MEK Inhibition for the Treatment of BRAF-Mutated Melanoma: Feedback Is Not Encouraged von Chapman, Paul B., Solit, David B., Rosen, Neal

Volltext

Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma von Bollag, Gideon, Hirth, Peter, Tsai, James, Zhang, Jiazhong, Ibrahim, Prabha N., Cho, Hanna, Spevak, Wayne, Zhang, Chao, Zhang, Ying, Habets, Gaston, Burton, Elizabeth A., Wong, Bernice, Tsang, Garson, West, Brian L., Powell, Ben, Shellooe, Rafe, Marimuthu, Adhirai, Nguyen, Hoa, Zhang, Kam Y. J., Artis, Dean R., Schlessinger, Joseph, Su, Fei, Higgins, Brian, Iyer, Raman, D’Andrea, Kurt, Koehler, Astrid, Stumm, Michael, Lin, Paul S., Lee, Richard J., Grippo, Joseph, Puzanov, Igor, Kim, Kevin B., Ribas, Antoni, McArthur, Grant A., Sosman, Jeffrey A., Chapman, Paul B., Flaherty, Keith T., Xu, Xiaowei, Nathanson, Katherine L., Nolop, Keith

Volltext

Evolutionary dynamics of cancer in response to targeted combination therapy von Bozic, Ivana, Reiter, Johannes G, Allen, Benjamin, Antal, Tibor, Chatterjee, Krishnendu, Shah, Preya, Moon, Yo Sup, Yaqubie, Amin, Kelly, Nicole, Le, Dung T, Lipson, Evan J, Chapman, Paul B, Diaz, Jr, Luis A, Vogelstein, Bert, Nowak, Martin A

Volltext

Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT) von Carvajal, Richard D, Piperno-Neumann, Sophie, Kapiteijn, Ellen, Chapman, Paul B, Frank, Stephen, Joshua, Anthony M, Piulats, Josep M, Wolter, Pascal, Cocquyt, Veronique, Chmielowski, Bartosz, Evans, T R Jeffry, Gastaud, Lauris, Linette, Gerald, Berking, Carola, Schachter, Jacob, Rodrigues, Manuel J, Shoushtari, Alexander N, Clemett, Delyth, Ghiorghiu, Dana, Mariani, Gabriella, Spratt, Shirley, Lovick, Susan, Barker, Peter, Kilgour, Elaine, Lai, Zhongwu, Schwartz, Gary K, Nathan, Paul

Volltext

Dynamic prognostication using conditional survival estimates von Zabor, Emily C., Gonen, Mithat, Chapman, Paul B., Panageas, Katherine S.

Volltext

Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study von McArthur, Grant A, Chapman, Paul B, Robert, Caroline, Larkin, James, Haanen, John B, Dummer, Reinhard, Ribas, Antoni, Hogg, David, Hamid, Omid, Ascierto, Paolo A, Garbe, Claus, Testori, Alessandro, Maio, Michele, Lorigan, Paul, Lebbé, Celeste, Jouary, Thomas, Schadendorf, Dirk, O'Day, Stephen J, Kirkwood, John M, Eggermont, Alexander M, Dréno, Brigitte, Sosman, Jeffrey A, Flaherty, Keith T, Yin, Ming, Caro, Ivor, Cheng, Suzanne, Trunzer, Kerstin, Hauschild, Axel

Volltext

Site and Timing of First Relapse in Stage III Melanoma Patients: Implications for Follow-Up Guidelines von ROMANO, Emanuela, SCORDO, Michael, DUSZA, Stephen W, COIT, Daniel G, CHAPMAN, Paul B

Volltext